These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors.
    Author: Bhargava HN, Pandey RN, Matwyshyn GA.
    Journal: Life Sci; 1983 May 02; 32(18):2096-101. PubMed ID: 6133201.
    Abstract:
    The effects of prolyl-leucyl-glycinamide and cyclo (leucyl-glycine) on morphine-induced antinociception in mice and on in vitro binding of 3H-ligands for opiate receptor subtypes (mu, delta and kappa) in the mouse brain homogenate were determined. Subcutaneous administration of either of the above peptides (1, 2, and 4 mg/kg) 10 min prior to the injection of morphine did not affect morphine-induced antinociception as evidenced by the identical ED50 values of morphine in vehicle and peptide treated groups. The binding of 3H-dihydromorphine and 3H-naloxone (mu receptors), 3H-D-Ala2-D-Leu5-enkephalin (delta receptors), and 3H-ethylketocyclazocine (kappa receptors) to opiate receptors in the mouse brain homogenate was also unaffected by both the peptides over a large concentration range. It is concluded that these peptides do not interact with brain opiate receptors.
    [Abstract] [Full Text] [Related] [New Search]